Close

Articles Posted in Product Liability

Updated:

Doctors Say It’s Already Over For Diabetes Drug Avandia

In treating diabetes, it might not matter much whether the Food and Drug Administration halts sales of the drug Avandia. An FDA committee of outside experts met last week to provide advice on whether any regulatory action — from stronger warnings to removal — is needed. The FDA has the…

Updated:

Dallas Texas Update: Pain Pumps & Arthoscopic Shoulder Surgery Risks

Patients undergoing arthroscopic shoulder surgery have received pain pumps to assist in their recovery. Now a new study suggests these pumps may deliver too much medicine, destroying cartilage and leading to a condition known as Postarthroscopic Glenohumeral Chondrolysis. A study by The American Journal of Sports Medicine identified intra-articular pain…

Updated:

GSK to Take Charge of $2.36B Related to Paxil, Avandia.

The New York Times (7/16, B2, Jolly, Harris) reports that UK pharmaceutical maker GlaxoSmithKline announced on July 15 that “it would take a second-quarter charge of $2.36 billion related to legal cases involving its drugs Avandia [rosiglitazone] and Paxil [paroxetine].” This announcement comes one “day after an American medical advisory…

Updated:

FDA: Avandia To Be Restricted

An FDA panel has made a recommendation to the agency that the controversial diabetes drug Avandia should either be taken off the market or its sales should be severely restricted. Avandia and its maker, GlaxoSmithKline, have recently come under fire for trial results that reveal that patients taking Avandia are…

Updated:

NYTimes says patients should seek Avandia alternatives.

The New York Times (7/5) editorialized that the recent controversy over the diabetes drug Avandia — with “two major studies” saying it “raises the risk of cardiovascular ailments” and the third yet-to-be-published study that “seemed to exonerate” the drug — should probably lead patients to ask their doctors about alternatives.…

Updated:

Avastin Causes Significant Kidney Damage in Some Patients.

The Los Angeles Times (7/1, Rick) reports that Avastin (bevacizumab) “can cause significant kidney damage in some patients,” according to a new study. Researchers, “reporting in this month’s issue of the Journal of the American Society of Nephrology…wrote that patients on Avastin were at increased risk of severe protein loss…

Updated:

Dallas CBS 11: North Texas Yaz Yasmin Lawsuits

We were recently featured on Dallas CBS Channel 11 evening news. Please click here to read the interview and watch the video link. Our client suffered massive brain damage following the use of Yaz. Legal News Tags, attorney yasmin, attorney yaz, birth control yasmin, birth control yaz, blood clots, Dallas…

Updated:

Update: 2 Studies Suggest Avandia Increases Risk of Heart Problems.

ABC World News (6/28, story 7, 2:20, Sawyer) reported, “Two major studies have found the medicine called Avandia [rosiglitazone] could create a significant new risk of heart attack and other serious problems.” The Washington Post (6/29, Stein) reports that one study, “involving more than 35,500 people, found that Avandia significantly…

Contact Us
Start Chat